Evaluating the potential of sNfL as a biomarker in MS management in the UK: insights from SUNLIT survey
Sharmilee Gnanapavan, Tarunya Arun, Paul Gallagher, Michael Rushworth, Jade Marsh, Nazanin R. Kondori · 2025
Read Evaluating the potential of sNfL as a biomarker in MS management in the UK: insights from SUNLIT survey by Sharmilee Gnanapavan, Tarunya Arun, Paul Gallagher, Michael Rushworth, Jade Marsh, Nazanin R. Kondori (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12836954.txt.
Description
A blood mark of nerve wear could ease the scan load in multiple sclerosis care, if clinics trust it. Sharmilee Gnanapavan and five co-authors surveyed UK clinicians in 2025 on that mark, a scrap of the nerve fiber's frame that leaks into blood when fibers break. Eighty-six took part, split between nerve doctors and MS nurses. Near all the doctors said they would use the test if it were at hand.
Most saw it as a guide at drug starts and swaps, and a way to space out costly scans. Grasp of the mark's ins and outs sat mid-way; most wanted more teaching, and few knew any rule book for it. Getting the test at all, and sways from age and weight, stood as the blocks. The team urge teaching and access to catch up with the will.
Catalog record
| CREATOR | Sharmilee Gnanapavan, Tarunya Arun, Paul Gallagher, Michael Rushworth, Jade Marsh, Nazanin R. Kondori |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |